Corning Incorporated announced a new line of microcarriers for large-scale vaccine and cell therapy manufacturing.
The microcarriers simplify the scale-up of attachment-dependent cells by providing a premeasured, sterile, ready-to-use product for direct transfer into bioreactors. This single-step microcarrier solution replaces several steps traditionally required and allows researchers to minimize lab preparation time and enhance manufacturing results.
The microcarriers offer Corning’s unique Synthemax II and Enhanced Attachment surface treatment options to maximize cell yield and viability, and are fully compatible with closed systems solutions packaging in customizable batch sizes starting at 10 g.
The new microcarriers represent the next step in Corning’s ongoing scale-up offerings, joining Corning CellSTACK culture chambers, Corning HYPERStack vessels, a full range of spinner flasks, and advanced cell-culture media solutions.